Surabhi Rathore

Surabhi Rathore

Auto-generated profile, based on publicly available information

Surabhi Rathore

CSIR Institute of Genomics & Integrative Biology, Mathura Road, New Delhi, 110025, India

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 November 2021 in Current Research in Structural Biology
Verified
Journal Article
Open access
SFSaman Fatihi
Saman Fatihi
SRSurabhi Rathore
Surabhi Rathore
APAnkit K. Pathak
Ankit K. Pathak
DGDeepanshi Gahlot
Deepanshi Gahlot
MMMitali Mukerji
Mitali Mukerji
LTLipi Thukral
Lipi Thukral
The recent release of SARS-CoV-2 genomic data from several countries has provided clues into the potential antigenic drift of the coronavirus population. In particular, the genomic instability observed in the spike protein necessitates immediate action and further exploration in the context of viral-host interactions. By temporally tracking 527,988 SARS-CoV-2 genomes, we identified invariant and hypervariable regions within the spike protein. We evaluated combination of mutations from SARS-CoV-2 lineages and found that maximum number of lineage-defining mutations were present in the N-terminal domain (NTD). Based on mutant 3D-structural models of known Variants of Concern (VOCs), we found that structural properties such as accessibility, secondary structural type, and intra-protein interactions at local mutation sites are greatly altered. Further, we observed significant differences between intra-protein networks of wild-type and Delta mutant, with the latter showing dense intra-protein contacts. Extensive molecular dynamics simulations of D614G mutant spike structure with hACE2 further revealed dynamic features with 47.7% of mutations mapping on flexible regions of spike protein. Thus, we propose that significant changes within spike protein structure have occurred that may impact SARS-CoV-2 pathogenesis, and repositioning of vaccine candidates is required to contain the spread of COVID-19 pathogen.

1 February 2024 in Pharmacogenomics
Verified
Journal Article
Closed access
ASAmbily Sivadas
Ambily Sivadas
SRSurabhi Rathore
Surabhi Rathore
SSS Sahana
S Sahana
BJBani Jolly
Bani Jolly
RBRahul C Bhoyar
Rahul C Bhoyar
VSVinod Scaria
Vinod Scaria
Aim: The CYP2D6 gene is highly polymorphic, causing large interindividual variability in the metabolism of several clinically important drugs. Materials & methods: The authors investigated the dive...

17 February 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
SFSaman Fatihi
Saman Fatihi
SRSurabhi Rathore
Surabhi Rathore
APAnkit K. Pathak
Ankit K. Pathak
DGDeepanshi Gahlot
Deepanshi Gahlot
MMMitali Mukerji
Mitali Mukerji
LTLipi Thukral
Lipi Thukral
The recent release of SARS-CoV-2 genomic data from several countries has provided clues into the potential antigenic drift of the coronavirus population. In particular, the genomic instability observed in the spike protein necessitates immediate action and further exploration in the context of viralhost interactions. By temporally tracking 527,988 SARS-CoV-2 genomes, we identified invariant and hypervariable regions within the spike protein. We evaluated combination of mutations from SARS-CoV-2 lineages and found that maximum number of lineage-defining mutations were present in the N-terminal domain (NTD). Based on mutant 3D-structural models of known Variants of Concern (VOCs), we found that structural properties such as accessibility, secondary structural type, and intra-protein interactions at local mutation sites are greatly altered. Further, we observed significant differences between intra-protein networks of wild-type and Delta mutant, with the latter showing dense intra-protein contacts. Extensive molecular dynamics simulations of D614G mutant spike structure with hACE2 further revealed dynamic features with 47.7% of mutations mapping on flexible regions of spike protein. Thus, we propose that significant changes within spike protein structure have occurred that may impact SARS-CoV-2 pathogenesis, and repositioning of vaccine candidates is required to contain the spread of COVID-19 pathogen.